MedTrace Logo

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

NCT05032053 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-07-24

No results posted yet for this study

Summary

To observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteomic methods to explore serological markers that can be used to accurately predict the prognosis of such patients.

Conditions

Interventions

DRUG

Antithrombotic drugs

The purpose of our study is to observe the effect of various antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds.

Sponsors & Collaborators

  • Ankang Central Hospital

    collaborator OTHER

  • Yan'an University Affiliated Hospital

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wen Jiang, Ph.D · Department of Neurology, Xijing Hospital, Fourth Military Medical University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2025-12-01
Completion
2026-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05032053 on ClinicalTrials.gov